Over-the-counter drug · UNAPPROVED DRUG OTHER
KRX Aesthetics PD-13 Therapy NDC 84755-0010
Methyl aminolevulinate hydrochloride 1.95 mg/15mL · Spray · Topical · KRX RESOURCES SDN. BHD.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84755-0010-1 | 84755001001 | 15 mL in 1 PACKAGE (84755-0010-1)Marketed from Jan 1, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- KRX Aesthetics PD-13 Therapy
- Generic name (nonproprietary)
- krx aesthetics pd-13 therapy
- Active ingredients
- Methyl aminolevulinate hydrochloride — 1.95 mg/15mL
- Dosage form
- Spray
- Route
- Topical
- Labeler
- KRX RESOURCES SDN. BHD.NDC labeler code 84755
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Porphyrinogens (Chemical structure)
- Identifiers
- Product ID 84755-0010_4e6af886-2e2f-0343-e063-6394a90ad095SPL ID 4e6af886-2e2f-0343-e063-6394a90ad095SPL set ID 4e6af886-2e2e-0343-e063-6394a90ad095UNII 7S73606O1A
- Pharmacologic class
- Porphyrin Precursor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N484755001001followed by a unit qualifier and the quantityPackage 84755-0010-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).
Excerpt only. Read the full label for complete information.
About NDC 84755-0010
- What is NDC 84755-0010?
- 84755-0010 is the product NDC for KRX Aesthetics PD-13 Therapy, Methyl aminolevulinate hydrochloride 1.95 mg/15mL spray, listed with the FDA by KRX RESOURCES SDN. BHD.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- KRX Aesthetics PD-13 Therapy.
- What is the active ingredient?
- Methyl aminolevulinate hydrochloride.
- Who is the labeler?
- KRX RESOURCES SDN. BHD., NDC labeler code 84755. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for KRX Aesthetics PD-13 Therapy?
- 1 other product NDC are listed under this name. See all KRX Aesthetics PD-13 Therapy NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other KRX Aesthetics PD-13 Therapy products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| KRX Aesthetics PD-13 Therapy | Methyl aminolevulinate hydrochloride 1.95 mg/15mL | SprayTopical | BY KIN AESTHETICS LLC | 87565-0010 | 87565-0010-01 |